The company has appointed Beth-Anne Lang as Vice President and Head of Global Regulatory Affairs and Christine Garrett as Vice President and Head of Global Project Management.
Both will join LEO Pharma on May 13.
Based in New Jersey
Beth-Anne Lang and Christine Garrett will be based in Madison, New Jersey and be part of LEO Pharma’s Global Development Team.
Beth-Anne Lang’s main responsibility will be to lead and transform the regulatory into an even more modern and global organization. Christine Garrett’s main responsibility will be to lead a new program management organization which will be key for LEO Pharma in order to strengthen the company’s global drug development capabilities and help make innovation available to patients faster, it states.
A key milestone
As part of the company’s 2025 strategy, LEO Pharma R&D has launched a series of initiatives to raise the bar scientifically and build new capabilities within rare diseases, disease understanding and precision medicine within the company – supported by new ways of working with data and advanced analytics. Among other, this includes the recent addition of a new Translational Medicine Unit in Boston.
“LEO Pharma is building the world’s best dermatology R&D organization, nothing less. The appointment of Beth-Anne Lang and Christine Garrett is a key milestone in achieving this ambition. Beth-Anne and Christine’s vast experience with global leadership roles in multi-country cross functional teams and diverse portfolios combined with their strong technical and scientific backgrounds will be critical in our constant quest for improving science to the benefit of patients,” says Christian Antoni, Head of Development, LEO Pharma.
Beth-Anne Lang comes to LEO Pharma with a broad regulatory experience in early and late development across several therapeutic areas and in biologics. Beth-Anne joins LEO Pharma from Takeda, where she has held a number of regulatory positions of increasing responsibility over the past 17 years, most recently as Vice President, Global Regulatory Affairs for marketed products. Among other, she has been a key driver in creating Takeda’s global regulatory strategies across multiple therapeutic areas and building the marketed products regulatory organization. She holds a Master in Business Administration from Marquette University and a Bachelor of Science in Food Science/Microbiology from the University of Illinois.
Christine Garrett joins LEO Pharma from a position as Global Project Leader for research & early development programs. Prior to this, she spent more than 16 years at Novartis in broad therapeutic areas across all phases of development, where she among other successfully built and led global project teams and cross-functional teams across research, development and commercial. Christine holds a Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology, a Post-Graduate Certificate in Pharma Business Development & Licensing from the University of Manchester, A Master’s Certificate in Applied Project Management from Villanova University as well as Bachelor of Science in Chemistry from the Rochester Institute of Technology.